German Industry Wants To Simplify 'Complicated' Switch Process
Executive Summary
The German Medicines Manufacturers´ Association
You may also be interested in...
Sandoz' Hexal Wins Landmark German Case Over Desloratadine Switch
Sandoz, through its Hexal subsidiary, has won an important case against the German Ministry of Health over a delayed prescription-to-OTC switch of desloratadine, which shows European Union Member States have got the authority to switch at a national level centrally authorized drugs.
Novartis Wins Landmark Case Against German Government Over Desloratadine Switch
Generics giant Novartis through its Hexal subsidiary has won an important case against the German Ministry of Health over a delayed prescription-to-OTC switch of desloratadine, which shows European Union Member States have got the authority to switch at a national level centrally authorized drugs.
Switching Can Help Normalize Self-Care – PAGB’s Michelle Riddalls
Automatic switch from pharmacy to general sales list status and leveraging the power of real-world data are two ways in which the UK's switch system can be made more efficient, according to the PAGB's new senior director of Regulatory Affairs, Michelle Riddalls.